<p>Scott T. Rottinghaus, Chief Medical Officer of Enanta Pharmaceuticals Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Enanta Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002064832-25-000065), on December 05, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

ENTA

<p>Scott T. Rottinghaus, Chief Medical Officer of Enanta Pharmaceuticals, reported selling common shares of the company. The original filing is available via EDGAR, the SEC's system. This AI-generated brief is for informational purposes and not financial advice.</p>

Enanta Pharmaceuticals Chief Medical Officer Scott T. Rottinghaus Reports Sale of Common Shares